# A Trial to Evaluate Safety and Efficacy of a Product Named VGN-R09b in Patients With Parkinson's Disease

> **NCT06480461** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Shanghai Vitalgen BioPharma Co., Ltd.** · enrollment: 39 (estimated)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** VGN-R09b

## Key facts

- **NCT ID:** NCT06480461
- **Lead sponsor:** Shanghai Vitalgen BioPharma Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-09-02
- **Primary completion:** 2026-09-10
- **Final completion:** 2030-09-10
- **Target enrollment:** 39 (ESTIMATED)
- **Last updated:** 2026-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06480461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06480461, "A Trial to Evaluate Safety and Efficacy of a Product Named VGN-R09b in Patients With Parkinson's Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06480461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*